HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of recurrent alveolar soft-part sarcoma of the tongue after external beam radiotherapy with iodine-125 seed brachytherapy.

AbstractBACKGROUND:
Alveolar soft part sarcoma (ASPS) is a rare type of soft tissue sarcoma. The infrequency of ASPS is such that it accounts for <1% of all soft tissue sarcomas and <0.1% of sarcomas concerning the head and neck, primarily those involving the orbit (48%) and tongue (25%). Traditional chemotherapy or radiotherapy of ASPS is often associated with poor outcome, even after comprehensive interventions.
METHODS AND RESULTS:
We performed iodine-125 ((125) I) seed brachytherapy under ultrasound guidance through a submandibular puncture in a 4-year-old boy with recurrent ASPS of the tongue. The prescription dose was 120 Gy; therefore, 35 (125) I seeds were implanted with 0.77 mCi per seed, the total amount of activity being 26.95 mCi. CT scans confirmed a complete response after the treatment.
CONCLUSION:
Our patient now has a recurrent-free survival of >30 months, an amount of time longer than the median rate described in the literature.
AuthorsNa Meng, Xiaomeng Zhang, Anyan Liao, Suqing Tian, Weiqiang Ran, Yang Gao, Jun Jie Wang
JournalHead & neck (Head Neck) Vol. 36 Issue 12 Pg. E125-8 (Dec 2014) ISSN: 1097-0347 [Electronic] United States
PMID24585519 (Publication Type: Case Reports, Journal Article)
Copyright© 2014 Wiley Periodicals, Inc.
Chemical References
  • Iodine Radioisotopes
Topics
  • Brachytherapy
  • Child, Preschool
  • Humans
  • Iodine Radioisotopes (administration & dosage)
  • Male
  • Neoplasm Recurrence, Local (diagnosis, radiotherapy)
  • Sarcoma, Alveolar Soft Part (diagnosis, radiotherapy)
  • Tongue Neoplasms (diagnosis, radiotherapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: